FindTrial
Sign In

Metabolic Syndrome and its association with menopausal symptoms

Metabolic Syndrome and its association with menopausal symptoms among postmenopausal women- A Cross Sectional Studyâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029001
Enrollment
150
Registered
2020-11-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N951- Menopausal and female climactericstates Health Condition 2: N958- Other specified menopausal and perimenopausal disorders Health Condition 3: N958- Other specified menopausal and perimenopausal disorders Health Condition 4: N952- Postmenopausal atrophic vaginitis Health Condition 5: N950- Postmenopausal bleeding Health Condition 6: N959- Unspecified menopausal and perimenopausal disorder

Interventions

None listed

Sponsors

Aiims Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: women > 40 years with more than twelve months of amenorrhea; who attained menopause naturally.

Exclusion criteria

Exclusion criteria: • Use of hormone therapy, chemotherapy • Pelvic radiotherapy due to cancer • Pelvic surgery including bilateral oophorectomy • Thyroid disease • Premature menopause

Design outcomes

Primary

MeasureTime frame
To identify the proportion of metabolic syndrome and to assess its relationship with menopausal symptoms.Timepoint: baseline—

Secondary

MeasureTime frame
1. To assess the frequency of depression, anxiety and stress among postmenopausal women with or without metabolic syndrome. 2. To assess the sexual profile of postmenopausal women with or without metabolic syndrome. Timepoint: 18 months—

Countries

India

Contacts

Public ContactPurvashi kumari

AIIMS Rishikesh

rmundhra54@yahoo.com8057482137

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026